Schröder B (2016) The multifaceted roles of the invariant chain CD74—more than just a chaperone. Biochim Biophys Acta 1863:1269–1281. https://doi.org/10.1016/j.bbamcr.2016.03.026

Article  CAS  PubMed  Google Scholar 

Calandra T, Roger T (2003) Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3:791–800. https://doi.org/10.1038/nri1200

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kapurniotu A, Gokce O, Bernhagen J (2019) The multitasking potential of alarmins and atypical chemokines. Front Med (Lausanne) 6:3. https://doi.org/10.3389/fmed.2019.00003

Article  PubMed  Google Scholar 

Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR, Dewor M, Georgiev I, Schober A, Leng L et al (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13:587–596. https://doi.org/10.1038/nm1567

Article  CAS  PubMed  Google Scholar 

Leng L, Metz CN, Fang Y, Xu J, Donnelly S, Baugh J, Delohery T, Chen Y, Mitchell RA, Bucala R (2003) MIF signal transduction initiated by binding to CD74. J Exp Med 197:1467–1476. https://doi.org/10.1084/jem.20030286

Article  CAS  PubMed  PubMed Central  Google Scholar 

Klasen C, Ohl K, Sternkopf M, Shachar I, Schmitz C, Heussen N, Hobeika E, Levit-Zerdoun E, Tenbrock K, Reth M et al (2014) MIF promotes B cell chemotaxis through the receptors CXCR4 and CD74 and ZAP-70 signaling. J Immunol 192:5273–5284. https://doi.org/10.4049/jimmunol.1302209

Article  CAS  PubMed  Google Scholar 

Schwartz V, Kruttgen A, Weis J, Weber C, Ostendorf T, Lue H, Bernhagen J (2012) Role for CD74 and CXCR4 in clathrin-dependent endocytosis of the cytokine MIF. Eur J Cell Biol 91:435–449. https://doi.org/10.1016/j.ejcb.2011.08.006

Article  CAS  PubMed  Google Scholar 

Schwartz V, Lue H, Kraemer S, Korbiel J, Krohn R, Ohl K, Bucala R, Weber C, Bernhagen J (2009) A functional heteromeric MIF receptor formed by CD74 and CXCR4. FEBS Lett 583:2749–2757. https://doi.org/10.1016/j.febslet.2009.07.058

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kontos C, El Bounkari O, Krammer C, Sinitski D, Hille K, Zan C, Yan G, Wang S, Gao Y, Brandhofer M et al (2020) Designed CXCR4 mimic acts as a soluble chemokine receptor that blocks atherogenic inflammation by agonist-specific targeting. Nat Commun 11:5981. https://doi.org/10.1038/s41467-020-19764-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sinitski D, Kontos C, Krammer C, Asare Y, Kapurniotu A, Bernhagen J (2019) Macrophage migration inhibitory factor (MIF)-based therapeutic concepts in atherosclerosis and inflammation. Thromb Haemost. https://doi.org/10.1055/s-0039-1677803

Article  PubMed  Google Scholar 

Shi X, Leng L, Wang T, Wang W, Du X, Li J, McDonald C, Chen Z, Murphy JW, Lolis E et al (2006) CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 25:595–606. https://doi.org/10.1016/j.immuni.2006.08.020

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alampour-Rajabi S, El Bounkari O, Rot A, Muller-Newen G, Bachelerie F, Gawaz M, Weber C, Schober A, Bernhagen J (2015) MIF interacts with CXCR7 to promote receptor internalization, ERK1/2 and ZAP-70 signaling, and lymphocyte chemotaxis. FASEB J 29:4497–4511. https://doi.org/10.1096/fj.15-273904

Article  CAS  PubMed  Google Scholar 

Ma H, Wang J, Thomas DP, Tong C, Leng L, Wang W, Merk M, Zierow S, Bernhagen J, Ren J et al (2010) Impaired macrophage migration inhibitory factor-AMP-activated protein kinase activation and ischemic recovery in the senescent heart. Circulation 122:282–292. https://doi.org/10.1161/circulationaha.110.953208

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heinrichs D, Knauel M, Offermanns C, Berres ML, Nellen A, Leng L, Schmitz P, Bucala R, Trautwein C, Weber C et al (2011) Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74. Proc Natl Acad Sci USA 108:17444–17449. https://doi.org/10.1073/pnas.1107023108

Article  PubMed  PubMed Central  Google Scholar 

Qi D, Hu X, Wu X, Merk M, Leng L, Bucala R, Young LH (2009) Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion. J Clin Investig 119:3807–3816. https://doi.org/10.1172/jci39738

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burton JD, Ely S, Reddy PK, Stein R, Gold DV, Cardillo TM, Goldenberg DM (2004) CD74 is expressed by multiple myeloma and is a promising target for therapy. Clin Cancer Res 10:6606–6611

Article  CAS  PubMed  Google Scholar 

Stein R, Mattes MJ, Cardillo TM, Hansen HJ, Chang CH, Burton J, Govindan S, Goldenberg DM (2007) CD74: a new candidate target for the immunotherapy of B-cell neoplasms. Clin Cancer Res 13:5556s–5563s. https://doi.org/10.1158/1078-0432.CCR-07-1167

Article  CAS  PubMed  Google Scholar 

De la Cruz-Mosso U, Garcia-Iglesias T, Bucala R, Estrada-Garcia I, Gonzalez-Lopez L, Cerpa-Cruz S, Parra-Rojas I, Gamez-Nava JI, Perez-Guerrero EE, Munoz-Valle JF (2018) MIF promotes a differential Th1/Th2/Th17 inflammatory response in human primary cell cultures: Predominance of Th17 cytokine profile in PBMC from healthy subjects and increase of IL-6 and TNF-alpha in PBMC from active SLE patients. Cell Immunol 324:42–49. https://doi.org/10.1016/j.cellimm.2017.12.010

Article  CAS  PubMed  Google Scholar 

Alibashe-Ahmed M, Roger T, Serre-Beinier V, Berishvili E, Reith W, Bosco D, Berney T (2019) Macrophage migration inhibitory factor regulates TLR4 expression and modulates TCR/CD3-mediated activation in CD4+ T lymphocytes. Sci Rep 9:9380. https://doi.org/10.1038/s41598-019-45260-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hernandez-Palma LA, Garcia-Arellano S, Bucala R, Llamas-Covarrubias MA, De la Cruz-Mosso U, Oregon-Romero E, Cerpa-Cruz S, Parra-Rojas I, Plascencia-Hernandez A, Munoz-Valle JF (2019) Functional MIF promoter haplotypes modulate Th17-related cytokine expression in peripheral blood mononuclear cells from control subjects and rheumatoid arthritis patients. Cytokine 115:89–96. https://doi.org/10.1016/j.cyto.2018.11.014

Article  CAS  PubMed  Google Scholar 

Gaber T, Schellmann S, Erekul KB, Fangradt M, Tykwinska K, Hahne M, Maschmeyer P, Wagegg M, Stahn C, Kolar P et al (2011) Macrophage migration inhibitory factor counterregulates dexamethasone-mediated suppression of hypoxia-inducible factor-1 alpha function and differentially influences human CD4+ T cell proliferation under hypoxia. J Immunol 186:764–774. https://doi.org/10.4049/jimmunol.0903421

Article  CAS  PubMed  Google Scholar 

Bacher M, Metz CN, Calandra T, Mayer K, Chesney J, Lohoff M, Gemsa D, Donnelly T, Bucala R (1996) An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA 93:7849–7854. https://doi.org/10.1073/pnas.93.15.7849

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matsumoto K, Kanmatsuse K (2001) Increased production of macrophage migration inhibitory factor by T cells in patients with IgA nephropathy. Am J Nephrol 21:455–464. https://doi.org/10.1159/000046649

Article  CAS  PubMed  Google Scholar 

Kim HK, Garcia AB, Siu E, Tilstam P, Das R, Roberts S, Leng L, Bucala R (2019) Macrophage migration inhibitory factor regulates innate gammadelta T-cell responses via IL-17 expression. FASEB J 33:6919–6932. https://doi.org/10.1096/fj.201802433R

Article  CAS  PubMed  PubMed Central  Google Scholar 

David JR (1966) Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell–antigen interaction. Proc Natl Acad Sci USA 56:72–77. https://doi.org/10.1073/pnas.56.1.72

Article  CAS  PubMed